Program

ABOUT THE BIOTECH CEO SUMMITS – UNLIKE ANY OTHER CONFERENCE

The Biotech CEO Summits are unlike most other meetings CEOs attend. The Summits focus on the participating CEOs discussing issues of importance to them as leaders of companies they want to position for growth and success. The Summits are discussion based meetings led by subject matter experts. All participants are invited to, and indeed encouraged to join the discussions by asking questions and sharing their personal insights. The Summits are run under Chatham House Rules to encourage open and frank conversation. The media are not invited, and the sessions are not recorded, to provide an extra layer of privacy.

2023 Biotech CEO Summit Agenda

Monday, July 17

 2:00 pm

Registration Opens: Maurice Braun Foyer – via Lobby

3:00 pm

Pre-Event: Gathering for Female Biotech CEOs: Charles Fries Room

  • Ciara Kennedy, CEO, Sorriso Pharmaceuticals
 5:00 pm

Welcome Networking Event: Arroyo Terrace
Drinks and Falconry Demonstration

 6:30 pm

Opening Program: Everett Jackson Room
Welcome Remarks

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 6:45 pm

CEO Summit Participant Introductions 
SelfIntroductions by all participants  

 7:30 pm

Fireside Chat Series: The Purposeful CEO – Fulfilling the Promise
Leading a team through change, innovation, and the challenges of bringing therapeutics to patients while the rules are still being written

Moderator:

  • Seema Kumar, CEO, Cure

Fireside Chat CEO:

  • Eric Dube, CEO, Travere Therapeutics
 8:15 pm

Networking Reception & Dinner: Alfred Mitchell Room

Tuesday, July 18

 7:00 am

Private Networking Breakfast: Charles Reiffel Room

 8:20 am

Summit Overview & Rules of Engagement: Maurice Braun Room

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 8:30 am

Opening Discussion: Looking at The Crystal Ball 
Discussion Leader:

  • Tim Opler, Managing Director, Emerald BioVentures

Discussants:

  • Rachelle Jacques, CEO, Akari Therapeutics
  • Gabriel Cavazos, Senior Managing Director, SVB Securities
 9:15 am

Managing What You Have: Taking Your Foot Off the Accelerator Now While Preparing To Go Full Throttle Later

Discussion Leader:

  • Kale Frank, Managing Director, Life Science and Healthcare, SVB

Discussants:

  • Sandra Dunn, CEO, Phoenix Molecular Designs
  • Thijs Spoor, CEO, Perspective Therapeutics
  • Nancy Stagliano, CEO, Neuron23
10:00 am Networking Break: Maurice Braun Patio
10:15 am

Creative Financing in Challenging Times: The Tools, Options, and Novel Approaches

Discussion Leader:

  • Carlos Ramirez, Partner, Cooley 

Discussants:

  • Gabriel Cavazos, Senior Managing Director, SVB Securities
  • Rachelle Jacques, CEO, Akari Therapeutics
  • Michael Tilghman, Director, SVB 
11:00 am

Asset Value Versus Enterprise Value: It’s Not What You Think

Discussion Leader:

  • Ted Haack, Vice President, LatticePoint

Discussants:

  • Sandra Dunn, CEO, Phoenix Molecular Designs
  • Ciara Kennedy, CEO, Sorriso Pharmaceuticals
  • Tim Opler, Partner, Emerald BioVentures
11:45 am

Building Value Through the Company Lifecycle: The Key to Successful BD & Fundraising

Discussion Leader:

  • Lila Hope, Partner, Cooley

Discussants:

  • Kerrie Brady, CEO, OcuTerra Therapeutics
  • Michael McCully, CEO, Gate Neurosciences Inc.
  • Thomas Tóth von Kiskér, CEO, Tillotts Pharma
12:30 pm

Networking Lunch: Arroyo Terrace

1:45 pm

A Case Study: The Finishing Touch: Maurice Braun Room

Discussion Leaders:

  • Ted Haack, Vice President, LatticePoint
  • Brandi Simpson, Vice President, BD, Voyager 
  • Robin Toft, Global Life Sciences & Boardroom Diversity Advisor, ZRG Partners
2:00 pm

Breakout Groups Report Out: Charles Fries Room & Charles Reiffel Room

2:30 pm

Breakouts Report Back: Maurice Braun Room
Teams Reconvene: Each team will present the specific challenges the CEO of their company faced and their recommendations for handling the situation.

Discussion Leaders:

  • Ted Haack, Vice President, LatticePoint
  • Brandi Simpson, Vice President, BD, Voyager
  • Robin Toft, Global Life Sciences & Boardroom Diversity Advisor, ZRG Partners
3:15 pm

AI in Biotech: Why We Should Care

Discussion Leader:

  • Bassil Dahiyat, CEO, Xencor, Inc.

Discussants:

  • Jacob Berlin, CEO, Terray Therapeutics
  • Benjamin Pensak, Partner, Morgan Lewis
  • Julie Visser, Managing Director, Executive Search, Human Capital Advisory Team, ZRG Partners, LLC
4:00 pm

The IRA:  How Will the Rules Affect Innovation and Your Business

Discussion Leader:

  • Seema Kumar, CEO, Cure

Discussants: 

  • Paul Hastings, CEO, Nkarta Therapeutics
  • Joseph Panetta, President & CEO, Biocom California
 5:00 pm

Day 1 Wrap-Up & Instructions for CEO Summit Games

  • Sara Jane Demy, Founder & CEO, Demy-Colton
  • Kari Bennett, Senior Marketing Advisor, Demy-Colton
 5:15 pm Biotech CEO Summit Games: Arroyo Terrace
7:15 pm Break
7:45 pm Networking Reception: Charles Fries Patio
 8:30 pm Biotech CEO Summit Gala Awards & Dinner: Charles Reiffel Room

Wednesday, July 19

 7:00 am

Private Networking Breakfast: Charles Reiffel Room

 8:25 am

Welcome Back & Day 2 Commences: Maurice Braun Room

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 8:30 am

Communications:  The Building Blocks for Successful Fundraising, Deal Making & Team Building Especially in Challenging Times

Discussion Leader:

  • Erik Clausen, Managing Partner, CG Life

Discussants:

  • Virginia Amann, CEO, Founder & Shareholder, ENTENTE Network
  • Dee Datta, CEO, Switch Therapeutics
 9:30 am

Your Board: Building the Trust and Engagement to Support Success

Discussion Leader:

  • Julie Visser, Managing Director, Executive Search, Human Capital Advisory Team, ZRG Partners, LLC

Discussants:

  • Paul Hastings, CEO, Nkarta & Former Chair, BIO
  • Joseph Payne, CEO, Arcturus Therapeutics
  • Leslie Williams, CEO, hC Bioscience
10:30 am Networking Break: Maurice Braun Patio
10:45 am

“Fit-for-Purpose”: Building, Scaling, and Evolving a Successful Biotech Company

Discussion Leader:

  • David Fortier, Managing Partner, Global Life Sciences Practice Leader, ZRG Partners

Discussants:

  • Michael Bailey, CEO, AVEO Oncology
  • Bassil Dahiyat, CEO, Xencor, Inc.
  • Nancy Stagliano, CEO, Neuron23
11:45 am

Big, Bold Ideas:  Building a Better, More Sustainable Biotech Community

Discussion Leader:

  • Jeffrey Cleland, Chairman, CEO & President, Ashvattha Therapeutics

Discussants:

  • Eric Dube, President & CEO, Travere Therapeutics, Inc.
  • Sofie Qiao, CEO, Vivace Therapeutics, Inc.
12:30 pm

Networking Lunch: Arroyo Terrace

 1:45 pm

Fireside Chat Series: The Purposeful CEO – Fulfilling the Promise: Maurice Braun Room
Building a company to address an unmet need.

Moderator:

  • Lila Hope, Partner, Cooley

Fireside Chat CEO:

  • Ted Love, Chairman, Biotechnology Industry Organization (BIO) 
 2:30 pm

An Unguarded Conversation Among Friends

  • Sara Jane Demy, Founder & CEO, Demy-Colton
3:00 pm

Wrap-Up Biotech CEO Summit

  • Sara Jane Demy, Founder & CEO, Demy-Colton
 3:15 pm

Closing Reception: Charles Fries Patio

 

 

List of 2023 Discussants

  • Gabriel Cavazos, Senior Managing Director, SVB Securities        
  • Erik Clausen, Managing Partner, CG Life
  • Jeff Cleland, CEO, Ashvattha Therapeutics*
  • Eric Dube, CEO, Travere Therapeutics
  • Kale Frank, Managing Director, Life Science and Healthcare, SVB
  • David Fortier, Managing Partner, Global Life Sciences Practice Leader, ZRG Partners, LLC*
  • Ted Haack, Vice President, LatticePoint*
  • Paul Hastings, President & CEO, Nkarta Therapeutics* 
  • Lila Hope, Partner, Cooley LLP
  • Seema Kumar, CEO, Cure
  • Ted Love, Chairman, Biotechnology Industry Organization (BIO)
  • Tim Opler, Managing Director, Global Healthcare Group, Stifel and Co-Founder, Emerald BioVentures*
  • Joe Panetta, CEO, Biocom California
  • Benjamin Pensak, Partner, Morgan Lewis
  • Carlos Ramirez, Partner, Cooley
  • Brandi Simpson, VP, Business and Corporate Development, Voyager Therapeutics
  • Michael Tilghman, Director, SVB
  • Thomas Tóth von Kiskér, CEO, Tillotts Pharma AG
  • Julie Visser, Managing Partner, Global Life Sciences Practice Leader, ZRG Partners, LLC
* Advisory Board Member